Thursday's coverage included more tech earnings, focus on Trump's latest on potential tariffs and more analysis around Monday ...

Twin Peaks – an American chain of sports bars and restaurants goes live on Nasdaq in what is the first restaurant debut of ...

Discover new preferred stock and exchange-traded debt offerings in January with yields up to 9.125%. Click here to read what ...

(Nasdaq: NDAQ) today reported financial results for the fourth quarter and full year of 2024. 2024 net revenues 1 were $4.

The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...

As a result, Renaissance expects a banner year for IPOs, with an estimated volume range of 155 to 195 IPOs in 2025 and $40 billion to $55 billion in new funding as the market "normalizes" in 2025. "A ...

A Waltham biotech focused on cystic fibrosis and a Boston biotech led by serial founder Gary Glick are the first ...

When we introduced the Nasdaq IPO Pulse a year ago, we said it suggested that U.S. “IPO activity… should remain in an uptrend” as we headed into 2024. Then, when we introduced the Nasdaq ...

Nukkleus announces it regains compliance with Nasdaq listing rules. The Nasdaq informs the company that it canceled the hearing scheduled for Jan. 21. Get Pro-Level Earnings Insights Before the ...

It was the biggest initial public offering (IPO) in history at the time ... of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Verona Pharma. Looking at options history for Verona Pharma VRNA we detected 14 trades. If we consider the specifics ...

Financial giants have made a conspicuous bearish move on Moderna. Our analysis of options history for Moderna MRNA revealed 28 unusual trades. Delving into the details, we found 17% of traders ...